We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$20.3B
AUM Growth
+$1.22B
Cap. Flow
-$160M
Cap. Flow %
-0.79%
Top 10 Hldgs %
22.03%
Holding
1,796
New
121
Increased
266
Reduced
599
Closed
60

Top Buys

Rank Stock Value
1
TE
T1 Energy
TE
+$60.5M
2
PFE icon
Pfizer
PFE
+$44M
3
GXO icon
GXO Logistics
GXO
+$37.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$31.2M
5
JD icon
JD.com
JD
+$29.6M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$57.2M
2
BABA icon
Alibaba
BABA
+$57.2M
3
AMRC icon
Ameresco
AMRC
+$55.4M
4
SIVB
SVB Financial Group
SIVB
+$43.1M
5
WOLF icon
Wolfspeed
WOLF
+$41.1M

Sector Composition

Rank Sector Weight
1 Technology 25.22%
2 Healthcare 17.92%
3 Consumer Discretionary 13.84%
4 Financials 12.09%
5 Industrials 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KPTI icon
1751
Karyopharm Therapeutics
KPTI
$46M
-693
Closed -$61K
LBRDA icon
1752
Liberty Broadband Class A
LBRDA
$5.07B
-3,403
Closed -$573K
MCRB icon
1753
Seres Therapeutics
MCRB
$47.4M
-1,825
Closed -$254K
MOMO
1754
Hello Group
MOMO
$867M
-101,334
Closed -$1.07M
OCFT
1755
DELISTED
OneConnect Financial Technology
OCFT
-12,240
Closed -$502K
OFIX icon
1756
Orthofix Medical
OFIX
$424M
-5,558
Closed -$212K
OMER icon
1757
Omeros
OMER
$992M
-17,300
Closed -$239K
SKYW icon
1758
Skywest
SKYW
$4.16B
-4,800
Closed -$237K
TAL icon
1759
TAL Education Group
TAL
$6.58B
-95,900
Closed -$464K
TBPH icon
1760
Theravance Biopharma
TBPH
$878M
-13,516
Closed -$100K
TCMD icon
1761
Tactile Systems Technology
TCMD
$555M
-6,000
Closed -$267K
TPIC
1762
DELISTED
TPI Composites
TPIC
-284,166
Closed -$9.59M
VSXY
1763
Victoria's Secret
VSXY
$7.39B
-15,149
Closed -$837K
YSG
1764
Yatsen Holding
YSG
$315M
-58,600
Closed -$1.12M
CTLT
1765
DELISTED
CATALENT, INC.
CTLT
-28,090
Closed -$3.74M
DCPH
1766
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-8,504
Closed -$289K
NGM
1767
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
-10,000
Closed -$210K
AMTI
1768
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
-9,200
Closed -$238K
ICPT
1769
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-13,165
Closed -$196K
CELL
1770
DELISTED
PhenomeX Inc. Common Stock
CELL
-11,600
Closed -$227K
RETA
1771
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-5,900
Closed -$594K
QUOT
1772
DELISTED
Quotient Technology Inc
QUOT
-19,346
Closed -$113K
AERI
1773
DELISTED
Aerie Pharmaceuticals
AERI
-13,051
Closed -$149K
RDUS
1774
DELISTED
Radius Health, Inc.
RDUS
-15,023
Closed -$186K
EPZM
1775
DELISTED
Epizyme, Inc
EPZM
-23,400
Closed -$120K

Similar funds

Handelsbanken Fonder's Q4 2021 Portfolio in Review

As of Q4 2021, Handelsbanken Fonder held 1,796 positions worth $20.3B, up 6.4% from $19.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Handelsbanken Fonder's Q4 2021 filing shows 121 new, 266 increased, 599 reduced and 60 closed positions. Its largest new stake was T1 Energy: 5,589,851 shares worth $62.5M. The largest sale was NVIDIA, an estimated $57.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Handelsbanken Fonder's largest Q4 2021 buy was T1 Energy: 5,589,851 shares worth $62.5M.
  • Handelsbanken Fonder added most to Pfizer in Q4 2021, an estimated $44M increase.
  • Handelsbanken Fonder's biggest Q4 2021 reduction was NVIDIA, cutting an estimated $57.2M.
  • Handelsbanken Fonder fully exited Acceleron Pharma in Q4 2021, selling an estimated $27.5M.
  • Handelsbanken Fonder's ten largest holdings make up 22% of its $20.3B portfolio in Q4 2021.
  • Handelsbanken Fonder opened 121 new positions and closed 60 in Q4 2021.
  • Handelsbanken Fonder's portfolio value rose 6.4% quarter-over-quarter to $20.3B.

Based on Handelsbanken Fonder's 13F filing for Q4 2021, filed 8 Feb 2022.